Allogeneic dendritic cells fused with tumor cells: preclinical results and outcome of a clinical phase I/II trial in patients with metastatic renal cell carcinoma.
暂无分享,去创建一个
P. Albers | T. Sauerbruch | I. Schmidt-Wolf | S. Müller | A. von Ruecker | R. Caspari | A. Eis-Hübinger | A. Märten | P. Hanfland | I. Schwaner | U. Mey | D. Flieger | T. Heinicke | S. Renoth | U. Lohmann | Andreas Pauli | Guido Heylmann
[1] P. Walden,et al. Recruitment of helper T cells for induction of tumour rejection by cytolytic T lymphocytes , 1994, Cancer Immunology, Immunotherapy.
[2] P. Schlag,et al. A rapid and simple procedure for dissociation of tumor tissue from the human colon , 2004, Journal of Cancer Research and Clinical Oncology.
[3] P. Albers,et al. Therapeutic vaccination against metastatic renal cell carcinoma by autologous dendritic cells: preclinical results and outcome of a first clinical phase I/II trial , 2002, Cancer Immunology, Immunotherapy.
[4] W. Linehan,et al. Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation. , 2000, The New England journal of medicine.
[5] S. Cannistra,et al. Fusions of Human Ovarian Carcinoma Cells with Autologous or Allogeneic Dendritic Cells Induce Antitumor Immunity1 , 2000, The Journal of Immunology.
[6] R. Motzer,et al. Effect of cytokine therapy on survival for patients with advanced renal cell carcinoma. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] W. Sterry,et al. Hybrid cell vaccination for cancer immune therapy: First clinical trial with metastatic melanoma , 2000, International journal of cancer.
[8] A. Gross,et al. Regression of human metastatic renal cell carcinoma after vaccination with tumor cell–dendritic cell hybrids , 2000, Nature Medicine.
[9] M. Probst-Kepper,et al. A New Antigen Recognized by Cytolytic T Lymphocytes on a Human Kidney Tumor Results from Reverse Strand Transcription , 1999, The Journal of experimental medicine.
[10] A. Schned,et al. In vivo description of dendritic cells in human renal cell carcinoma. , 1999, The Journal of urology.
[11] V. Paradis,et al. Molecular expression of PSMA mRNA and protein in primary renal tumors , 1999, International journal of cancer.
[12] G. Bartsch,et al. CD83+ blood dendritic cells as a vaccine for immunotherapy of metastatic renal-cell cancer , 1998, The Lancet.
[13] R. Steinman,et al. Dendritic cells and the control of immunity , 1998, Nature.
[14] S. Rafii,et al. Dendritic Cells Genetically Modified with an Adenovirus Vector Encoding the cDNA for a Model Antigen Induce Protective and Therapeutic Antitumor Immunity , 1997, The Journal of experimental medicine.
[15] R. Steinman,et al. Dendritic Cells as Adjuvants for Immune-mediated Resistance to Tumors , 1997, The Journal of experimental medicine.
[16] S. Rosenberg,et al. Dendritic Cells Retrovirally Transduced with a Model Antigen Gene Are Therapeutically Effective against Established Pulmonary Metastases , 1997, The Journal of experimental medicine.
[17] C. Colaco,et al. Immunotherapy: Fusion induces tumour rejection , 1997, Nature.
[18] D. Kufe,et al. Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells , 1997, Nature Medicine.
[19] R. Motzer,et al. Renal-cell carcinoma. , 1996, The New England journal of medicine.
[20] E. Gilboa,et al. Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo , 1996, The Journal of experimental medicine.
[21] E. Lopez Hänninen,et al. Interleukin-2 based home therapy of metastatic renal cell carcinoma: risks and benefits in 215 consecutive single institution patients. , 1996, The Journal of urology.
[22] K. Wiesmüller,et al. Efficacy of synthetic vaccines in the induction of cytotoxic T lymphocytes. Comparison of the costimulating support provided by helper T cells and lipoamino acid. , 1994, Journal of immunological methods.
[23] A. Yagoda. Chemotherapy of renal cell carcinoma: 1983-1989. , 1989, Seminars in urology.
[24] T. Logtenberg,et al. Enumeration of IFN-γ-producing human lymphocytes by spot-ELISA: A method to detect lymphokine-producing lymphocytes at the single-cell level , 1988 .
[25] T. Lövgren,et al. Europium-labelled target cells in an assay of natural killer cell activity. I. A novel non-radioactive method based on time-resolved fluorescence. , 1986, Journal of immunological methods.
[26] R. D. Hunter,et al. WHO Handbook for Reporting Results of Cancer Treatment , 1980 .